Unknown

Dataset Information

Local FK506 delivery induces osteogenesis in in vivo rat bone defect and rabbit spine fusion models.


ABSTRACT: Bone grafting procedures are commonly used for the repair, regeneration, and fusion of bones in in a wide range of orthopaedic surgeries, including large bone defects and spine fusion procedures. Autografts are the clinical gold standard, though recombinant human bone morphogenetic proteins (rhBMPs) are often used, particularly in difficult clinical situations. However, treatment with rhBMPs can have off-target effects and significantly increase surgical costs, adding to patients' already high economic and mental burden. Recent studies have identified that FDA-approved immunosuppressant drug, FK506 (Tacrolimus), can also activate the BMP pathway by binding to its inhibitors. This study tested the hypothesis that FK506, as a standalone treatment, could induce osteogenic differentiation of h

SUBMITTER: Harrer JA 

PROVIDER: S-EPMC10979893 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature